A woman experienced severe vomiting and pain due to cannabinoid hyperemesis syndrome (CHS), a condition linked to heavy marijuana use, which can only be cured by quitting cannabis.
The incidence of cannabinoid hyperemesis syndrome (CHS), a condition causing severe vomiting and abdominal pain due to marijuana use, has doubled since 2017, affecting an estimated 2.75 million Americans annually. The rise is attributed to increased marijuana potency and availability. CHS can lead to life-threatening dehydration and other complications, with frequent users, especially those starting before age 16, at higher risk. Treatment involves anti-nausea medication and rehydration, and cessation of marijuana use is advised to prevent recurrence.
Cannabinoid Hyperemesis Syndrome (CHS), a condition characterized by nausea, vomiting, and abdominal pain, is increasingly affecting cannabis users, with emergency visits doubling in the U.S. and Canada from 2017 to 2021. The rise is linked to increased cannabis potency and accessibility due to legalization. CHS primarily affects heavy, long-term users and is thought to involve the endocannabinoid system and stress response. Diagnosis requires cannabis cessation, which can be challenging due to withdrawal symptoms. Treatment includes hydration, anti-nausea medications, and potentially quitting cannabis.